Use of herbal drugs to treat COVID-19 should be with caution

Yang, Yichang

doi:10.1016/s0140-6736(20)31143-0

Cited by 105 publications

(94 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We are aware that some herbal medicines are showing promise based on in vitro and small-scale clinical studies (Ang et al, 2020;Luo E. et al, 2020;Vellingiri et al, 2020;Yang, 2020;Zhang L. et al, 2020). However, their use outside of such studies is a concern until more data becomes available especially if their use causes delay in patients seeking appropriate care from healthcare professionals as their symptoms develop (Yang, 2020).…”

Section: Prevention and Treatment Of Covid-19mentioning

confidence: 99%

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Ogunleye

Basu

Mueller³

et al. 2020

Front. Pharmacol.

176

215

View full text Add to dashboard Cite

Background: The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. Objective: Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. Our Approach: Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. Ongoing Activities: Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on Ogunleye et al. COVID-19 in Africa NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. Conclusion: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.

show abstract

Section: Prevention and Treatment Of Covid-19mentioning

confidence: 99%

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Ogunleye

Basu

Mueller³

et al. 2020

Front. Pharmacol.

176

215

View full text Add to dashboard Cite

show abstract

“…As of September 21, 2020, there were 30,905,162 confirmed cases of COVID-19 [6], and, to date, no definitive treatments or vaccines are available to treat or prevent this viral infection. This situation has increased the influence of social media regarding misinformation about medications, leading to public confusion and panic and increased use of SM, including home remedies, without established safety and efficacy [7,8].…”

mentioning

confidence: 99%

“…Many herbal drugs have been used to treat COVID-19 in China, Pakistan, and other countries worldwide. Such products are readily available to the public without a prescription and are used as SM to avoid hospital visits and admissions, but their use in COVID-19 lacks evidence-based support [7]. In China, three patented herbal products (Lianhuaqingwen capsules and Jinhua Qinggan granules to treat mild conditions, and Xuebijing for severe conditions) were recommended to treat COVID-19.…”

mentioning

confidence: 99%

“…In China, three patented herbal products (Lianhuaqingwen capsules and Jinhua Qinggan granules to treat mild conditions, and Xuebijing for severe conditions) were recommended to treat COVID-19. However, their potential effectiveness and safety needs to be confirmed by the results of randomized controlled clinical trials before being used to treat COVID-19 [7]. Similarly, there was increased demand and use of Sanna Makki, a herbal plant, by local people in Pakistan due to its claimed efficacy in treating COVID-19 symptoms [16].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Self-medication during Covid-19 pandemic: challenges and opportunities

Malik

Tahir

Jabbar

et al. 2020

Drugs Ther Perspect

138

View full text Add to dashboard Cite

“…The author of the Lancet submission [1] took issue with three herbal drugs that were approved in China for the treatment of coronavirus disease 2019 (COVID-19). They cited lack of evidence for their efficacy and safety concerns, but also voiced other reasons why China should not have approved these herbal drugs for treating respiratory symptoms of COVID-19.…”

Section: Introductionmentioning

confidence: 99%

Dangers of scientific bias against herbal drugs for coronavirus disease 2019

Fields

2020

Journal of Integrative Medicine

View full text Add to dashboard Cite

On May 15, 2020, the Lancet published an article titled Use of Herbal Drugs to Treat COVID-19 Should be with Caution . While this is true of all drugs, herbal and otherwise, the data may be biased and deserve a scientific response. We believe these types of reports will unfairly and negatively impact the field of integrative medicine as a whole, and must be answered with facts and statistics that more accurately represent the current situation.

show abstract

Use of herbal drugs to treat COVID-19 should be with caution

Cited by 105 publications

References 7 publications

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Self-medication during Covid-19 pandemic: challenges and opportunities

Dangers of scientific bias against herbal drugs for coronavirus disease 2019

Contact Info

Product

Resources

About